Stock Analysis

Balaji Amines Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St

June 24, 2024

Balaji Amines (NSE:BALAMINES) Full Year 2024 Results

Key Financial Results

Revenue: ₹16.4b (down 30% from FY 2023).
Net income: ₹2.05b (down 37% from FY 2023).
Profit margin: 13% (down from 14% in FY 2023). The decrease in margin was driven by lower revenue.
EPS: ₹63.22 (down from ₹100 in FY 2023).

revenue-and-expenses-breakdown — NSEI:BALAMINES Revenue and Expenses Breakdown June 24th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Balaji Amines EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.2%.

The primary driver behind last 12 months revenue was the Chemicals (Including BSCPL - Subsidiary) segment contributing a total revenue of ₹16.4b (100% of total revenue). Notably, cost of sales worth ₹9.14b amounted to 56% of total revenue thereby underscoring the impact on earnings.Explore how BALAMINES's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India.

Performance of the Indian Chemicals industry.

The company's shares are up 7.8% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Balaji Amines that you need to take into consideration.

Valuation is complex, but we're helping make it simple.

Find out whether Balaji Amines is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.